NMO-IgG Status in Fulminant Inflammatory CNS Demyelinating Disorders

BACKGROUND: The aquaporin-4-specific serum autoantibody, NMO-IgG, is a validated biomarker distinguishing neuromyelitis optica spectrum disorders (NMOSD) from multiple sclerosis (MS). Because fulminant attacks are more common in NMOSD than MS, some suggest that NMO-IgG may be a marker of destructive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Magaña, Setty M., Pittock, Sean J., Lennon, Vanda A., Keegan, B. Mark, Weinshenker, Brian G., Lucchinetti, Claudia F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2742779/
https://ncbi.nlm.nih.gov/pubmed/19667216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2009.152
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares